JANE STREET GROUP, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 151 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$7,189,811
+0.0%
70,516
-10.8%
0.00%
-33.3%
Q1 2023$7,186,590
+266.4%
79,043
+53.1%
0.00%
+200.0%
Q4 2022$1,961,234
-15.5%
51,625
-32.4%
0.00%0.0%
Q2 2022$2,320,000
-57.7%
76,351
-54.4%
0.00%
-50.0%
Q1 2022$5,482,000
+141.1%
167,329
+94.1%
0.00%
Q4 2021$2,274,000
-81.2%
86,222
-28.3%
0.00%
-100.0%
Q3 2021$12,093,000
-8.7%
120,183
+28.5%
0.00%
-20.0%
Q2 2021$13,241,000
+21.2%
93,561
-14.6%
0.01%
-16.7%
Q1 2021$10,925,000
+42.6%
109,574
+76.8%
0.01%
+50.0%
Q4 2020$7,661,000
-43.2%
61,974
-55.2%
0.00%
-50.0%
Q3 2020$13,491,000
-3.3%
138,489
+54.8%
0.01%
-20.0%
Q2 2020$13,955,000
+15.0%
89,446
+6.4%
0.01%
-16.7%
Q1 2020$12,131,000
+847.0%
84,054
+1241.2%
0.01%
+500.0%
Q4 2019$1,281,000
+442.8%
6,267
+127.2%
0.00%
Q1 2019$236,0002,7580.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$288,821,00055.24%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 100,000$9,970,00015.20%
Tolleson Wealth Management, Inc. 108,000$10,768,0003.25%
MADDEN SECURITIES Corp 34,787$3,468,0002.03%
Biondo Investment Advisors, LLC 101,204$10,090,0002.01%
LBJ Family Wealth Advisors, Ltd. 30,368$3,027,0001.91%
Duquesne Family Office 749,897$74,765,0001.65%
Sofinnova Investments, Inc. 238,520$23,780,0001.43%
Camber Capital Management LP 400,000$39,880,0001.37%
Integral Health Asset Management, LLC 44,000$4,387,0001.25%
View complete list of REATA PHARMACEUTICALS INC shareholders